Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Do you recommend prophylactic ureteral stenting in patients who have recently completed SBRT to a region in close proximity to the ureter prior to the potential development of fibrosis?
Answer from: Radiation Oncologist at Community Practice
No, just F/U MRI.
Sign in or Register to read more
12725
Related Questions
How do you approach Lu-177 use in taxane-naive patients with metastatic prostate cancer?
Given the different rates of testosterone recovery, do you alter the duration of ADT when using Leuprorelin (GnRH Agonist) vs relugolix (GnRH antagonist) in patients with intermediate or high-risk prostate cancer who received definitive radiation?
How do you talk to patients with intermediate-risk prostate cancer deciding between LDR brachytherapy (monotherapy) vs HDR mono vs SBRT vs EBRT, in terms of the comparative side effect profile of each approach?
Given results of the RADICALS trials, is LT-ADT standard of care for salvage prostate RT?
How would you manage a patient who developed an intraprostatic abscess after SpaceOAR injection, prior to starting radiation?
How do you follow/manage patients with metastatic prostate cancer with undetectable PSA and castration-sensitive but active disease on PSMA PET?
Is there any evidence for amyloid/amyloidosis causing a spurious/false PSA reading?
How do you design pelvic lymph node treatment volumes for patients with tortuous or aberrant vascular anatomy?
How do you approach radiotherapy planning when there is no identifiable prostate tissue after HIFU or TURP?
How would you treat a patient with a post prostatectomy biochemical and pelvic nodal recurrence with a BLM mutation?